KeyBanc Keeps a Buy Rating on Veeva Systems (VEEV)

KeyBanc analyst Brent Bracelin maintained a Buy rating on Veeva Systems (NYSE: VEEV) today. The company’s shares closed yesterday at $98.14.

Bracelin observed:

“We are raising out PT to $108 from $99 to reflect the AI opportunity in life sciences coupled with an increasing number of customers planning to go “all-in” on a proven product portfolio.”

According to, Bracelin is a top 25 analyst with an average return of 24.6% and a 76.3% success rate. Bracelin covers the Technology sector, focusing on stocks such as Tyler Technologies,, and Everbridge Inc.

Veeva Systems has an analyst consensus of Moderate Buy, with a price target consensus of $99.25.

See today’s analyst top recommended stocks >>

Veeva Systems’ market cap is currently $14.15B and has a P/E ratio of 93.47. The company has a Price to Book ratio of 13.47.

Based on the recent corporate insider activity of 99 insiders, corporate insider sentiment is negative on the stock. Last month, Eleni Nitsa Zuppas, the CMO of VEEV sold 3,800 shares for a total of $395,048.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Veeva Systems, Inc. engages in the provision of industry-specific, cloud-based software solutions for the life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm’s customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage a regulated, content-centric processes across the enterprise. The company’s customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007 and is headquartered in Pleasanton, CA.

From Our Partners